Back

The association of Xylitol and incident cardiovascular events: the CLSA and EPIC-Norfolk cohort studies

29 August 2026 (10:15 - 10:45)
Organised by: Logo
Congress Presentation Part of: Hungry heart: nutrient deficiencies and cardiovascular disease Nutrition, Malnutrition and Heart Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marco Witkowski

Charite University Hospital, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail
Impact of vitamin B12 and folate deficiency anemias on cardiorenal outcomes in HFrEF
Doctor J. Hicks (Atlanta, US)
Abstract Slides
Presentation thumbnail
Joint associations of low-density lipoprotein cholesterol and prognostic nutritional index with mortality: a prospective cohort study in UK Biobank
Mr L. Li (Tianjin, CN)
Abstract Slides
Presentation thumbnail
Prospective associations of food insecurity and ultra-processed food consumption with diabetes risk in older adults
Miss S. Wu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Epidemiology and clinical outcomes of malnutrition in hospital admissions for acute myocardial infarction in Switzerland, 1998–2022
Ms A. Tanweer (Lausanne, CH)
Abstract Slides

Access the full session

Session thumbnail
Hungry heart: nutrient deficiencies and cardiovascular disease

The Event

Event poster

ESC Congress 2026

29 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Salt consumption as a predictor of cardiovascular events among hypertensive patients: a 5-year follow-up study
3 September 2019
thumbnail
Congress Presentation
Circulating hexose-derived metabolites are biomarker candidates for diabetes risk prediction
28 August 2023
thumbnail
Congress Presentation
Impact of history of vascular disease on lipoprotein(a) associations with cardiovascular outcomes: a Mendelian randomisation study in 283,658 UK Biobank participants
1 September 2019
thumbnail
Congress Presentation
Qualifying event proximity, cardiovascular risk, and benefit of empagliflozin in patients with type 2 diabetes and stable atherosclerosis in the EMPA-REG OUTCOME trial
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources